Exercise Physiology Laboratory, Department of Integrative Biology, University of California, Berkeley California, USA.
Am J Physiol Regul Integr Comp Physiol. 2011 Sep;301(3):R769-74. doi: 10.1152/ajpregu.00206.2011. Epub 2011 Jun 15.
Shuttling of intermediary metabolites, such as pyruvate, contributes to the dynamic energy and biosynthetic needs of tissues. Tracer kinetic studies offer a powerful tool to measure the metabolism of substrates like pyruvate that are simultaneously taken up from and released into the circulation by organs. However, we understood that during each circulatory passage, the entire cardiac output transits the pulmonary circulation. Therefore, we examined the transpulmonary pyruvate kinetics in an anesthetized rat model during an unstimulated (Con), lactate clamp (LC), and epinephrine infusion (Epi) conditions using a primed-continuous infusion of [U-¹³C]pyruvate. Compared with Con and Epi stimulation, LC significantly increased mixed central venous ([v]) and arterial ([a]) pyruvate concentrations (P < 0.05). We hypothesized that the lungs, specifically the pulmonary capillary beds are sites of simultaneous production and removal of pyruvate and contributes significantly to whole body carbohydrate intermediary metabolism. Transpulmonary net pyruvate balances were positive during all three conditions, indicating net pyruvate uptake. Net balance was significantly greater during epinephrine stimulation compared with the unstimulated control (P < 0.05). Tracer-measured pyruvate fractional extraction averaged 42.8 ± 5.8% for all three conditions and was significantly higher during epinephrine stimulation (P < 0.05) than during either Con or LC conditions, that did not differ from each other. Pyruvate total release (tracer measured uptake - net balance) was significantly higher during epinephrine stimulation (400 ± 100 μg/min) vs. Con (30 ± 20 μg/min) (P < 0.05). These data are interpreted to mean that significant pyruvate extraction occurs during circulatory transport across lung parenchyma. The extent of pulmonary parenchymal pyruvate extraction predicts high expression of monocarboxylate (lactate/pyruvate) transporters (MCTs) in the tissue. Western blot analysis of whole lung homogenates detected three isoforms, MCT1, MCT2, and MCT4. We conclude that a major site of circulating pyruvate extraction resides with the lungs and that during times of elevated circulating lactate, pyruvate, or epinephrine stimulation, pyruvate extraction is increased.
中间代谢产物(如丙酮酸)的穿梭作用有助于组织的动态能量和生物合成需求。示踪动力学研究提供了一种强大的工具,可以测量同时从器官摄取并释放到循环中的底物(如丙酮酸)的代谢。然而,我们了解到,在每次循环过程中,整个心输出量都会通过肺循环。因此,我们在麻醉大鼠模型中,使用[U-¹³C]丙酮酸的脉冲-连续输注,在未刺激(Con)、乳酸盐钳夹(LC)和肾上腺素输注(Epi)条件下,检查了跨肺丙酮酸动力学。与 Con 和 Epi 刺激相比,LC 显著增加了混合中心静脉([v])和动脉([a])丙酮酸浓度(P < 0.05)。我们假设,肺,特别是肺毛细血管床,是同时产生和去除丙酮酸的部位,对全身碳水化合物中间代谢有重要贡献。在所有三种情况下,跨肺净丙酮酸平衡均为正值,表明净丙酮酸摄取。与未刺激对照相比,在肾上腺素刺激下,净平衡显著更大(P < 0.05)。示踪剂测量的丙酮酸分数提取在所有三种情况下平均为 42.8 ± 5.8%,在肾上腺素刺激下显著更高(P < 0.05),而在 Con 或 LC 条件下则没有差异。丙酮酸总释放(示踪剂测量的摄取-净平衡)在肾上腺素刺激时(400 ± 100 μg/min)显著高于 Con 时(30 ± 20 μg/min)(P < 0.05)。这些数据表明,在肺实质的循环运输过程中,丙酮酸的提取量很大。肺实质丙酮酸提取的程度预测组织中单羧酸(乳酸/丙酮酸)转运体(MCT)的高表达。对整个肺匀浆的 Western blot 分析检测到三种同工型,MCT1、MCT2 和 MCT4。我们得出结论,循环丙酮酸提取的主要部位位于肺部,并且在循环中乳酸、丙酮酸或肾上腺素刺激升高时,丙酮酸提取增加。